Racemic sotalol has demonstrated anti-arrhythmic properties which include Class II (β blockade) and Class III (potassium channel blockade) activity. The Class II activity is demonstrated primarily in l-sotalol, and Class III activity is almost equipotent in each isomer. Class II and Class III activity of dl-sotalol was investigated following repeated oral administration (80mg b. i. d.) for 7 days. Class II activity was evaluated according to the low frequency spectral power obtained by fast Fourier analysis of the R-R interval variation. Class III activity was evaluated according to the change in the QTc interval of the surface electrocardiogram. The low frequency spectral power decreased after administration of the first dose on day 1 and ...
Objectives.This clinical study was designed to compare rate-dependent effects of class III agents on...
Sotalol is a β blocker that has also been reported to exert class III antiarrhythmic effects. To eva...
AbstractObjectives. We sought to determine the electrophysiologic mechanisms explaining the efficacy...
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potenti...
Although discovered more than two decades ago, the clinical applications of sotalol are still a matt...
d.l-Sotalol is a racemic drug composed of equimolar amounts ofd-(+)-sotalol and l-(—)-sotalol. The l...
QT interval dispersion measured as interlead variability of QT, is a marker of dispersion of ventric...
The inotropic effects ofsotalol in comparison to other antiarrhythmic drugs were tested in an experi...
Sotalol is a unique beta-adrenergic blocking agent with additional actions characteristic of Vaughn-...
The anti-arrhythmic efficacy of sotalol, aβ-blocking agent which possesses class III anti-arrhythmic...
AbstractSotalol is unique among beta-adrenergic blocking drugs in possessing significant class III a...
Studies in animals have shown that drug-induced action potential prolongation with class III antiarr...
Antiarrhythmic agents with class I action have been available for decades, and those with class III ...
Considering the Survival With ORal D-sotalol (SWORD) study results, in which mortality was higher in...
o evaluate the clinical efficacy of d-sotalol, 84 patients with a history of sustained ventricular t...
Objectives.This clinical study was designed to compare rate-dependent effects of class III agents on...
Sotalol is a β blocker that has also been reported to exert class III antiarrhythmic effects. To eva...
AbstractObjectives. We sought to determine the electrophysiologic mechanisms explaining the efficacy...
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potenti...
Although discovered more than two decades ago, the clinical applications of sotalol are still a matt...
d.l-Sotalol is a racemic drug composed of equimolar amounts ofd-(+)-sotalol and l-(—)-sotalol. The l...
QT interval dispersion measured as interlead variability of QT, is a marker of dispersion of ventric...
The inotropic effects ofsotalol in comparison to other antiarrhythmic drugs were tested in an experi...
Sotalol is a unique beta-adrenergic blocking agent with additional actions characteristic of Vaughn-...
The anti-arrhythmic efficacy of sotalol, aβ-blocking agent which possesses class III anti-arrhythmic...
AbstractSotalol is unique among beta-adrenergic blocking drugs in possessing significant class III a...
Studies in animals have shown that drug-induced action potential prolongation with class III antiarr...
Antiarrhythmic agents with class I action have been available for decades, and those with class III ...
Considering the Survival With ORal D-sotalol (SWORD) study results, in which mortality was higher in...
o evaluate the clinical efficacy of d-sotalol, 84 patients with a history of sustained ventricular t...
Objectives.This clinical study was designed to compare rate-dependent effects of class III agents on...
Sotalol is a β blocker that has also been reported to exert class III antiarrhythmic effects. To eva...
AbstractObjectives. We sought to determine the electrophysiologic mechanisms explaining the efficacy...